000 01565 a2200433 4500
005 20250517232816.0
264 0 _c20190819
008 201908s 0 0 eng d
022 _a1543-8392
024 7 _a10.1021/acs.molpharmaceut.8b00581
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMehta, Dharmini
245 0 0 _aReducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker.
_h[electronic resource]
260 _bMolecular pharmaceutics
_c10 2018
300 _a4568-4576 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aA549 Cells
650 0 4 _aAnimals
650 0 4 _aCathepsin B
_xchemistry
650 0 4 _aCathepsins
_xchemistry
650 0 4 _aDendrimers
_xchemistry
650 0 4 _aDoxorubicin
_xchemistry
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Liberation
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPolyethylene Glycols
_xchemistry
650 0 4 _aPolylysine
_xchemistry
650 0 4 _aRats
700 1 _aLeong, Nathania
700 1 _aMcLeod, Victoria M
700 1 _aKelly, Brian D
700 1 _aPathak, Rashmi
700 1 _aOwen, David J
700 1 _aPorter, Christopher J H
700 1 _aKaminskas, Lisa M
773 0 _tMolecular pharmaceutics
_gvol. 15
_gno. 10
_gp. 4568-4576
856 4 0 _uhttps://doi.org/10.1021/acs.molpharmaceut.8b00581
_zAvailable from publisher's website
999 _c28729956
_d28729956